Today, biotechnology is no longer the product of most companies that utilize it. Instead, biotechnology is quickly becoming a major methodology for delivering non-biotech products and services in ...

NEW YORK, Nov. 04, 2020 (GLOBE NEWSWIRE) -- Fortress Biotech ... generating company focused on acquiring, developing and commercializing or monetizing promising biopharmaceutical products and ...

“We are honored to be selected by the ASCO committee with our late breaking abstract poster ... About Purple Biotech Purple Biotech Ltd. (NASDAQ/TASE: PPBT) is a clinical-stage company ...

In this article, we will be taking a look at the most profitable biotechnology company in the world ... and the use of biotechnology products in food processing. DNA sequencing held the largest ...

PanGIA Biotech, a company advancing urine-based ... biopsy (Abstract #3080), has been accepted for presentation in the poster session titled Developmental Therapeutics—Molecularly Targeted ...

Oct. 08, 2024 (GLOBE NEWSWIRE) -- NKGen Biotech Inc. (Nasdaq ... A copy of the posters will be added to the Scientific Publications page of the Company’s website at https://nkgenbiotech.com ...

Biopharmaceutical company recognized for innovation in the development of immune-modulatory therapeutic cancer vaccines – NEW YORK, March 18, 2025 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq ...

IO Biotech (IOBT), a clinical-stage biopharmaceutical company developing novel, immune modulating cancer vaccines based on its T-win ® technology platform, today announced three poster ...

BRANDI: A LATE STAGE BIOTECH COMPANY ANNOUNCING ITS EXPANDING TO SACRAMENTO ... A 100,000-square-foot, state-of-the-art production facility that promises another step away from Sacramento's ...

The San Diego-based biotechnology company announced its $277 million ... There are approximately 190 Aviti products installed globally in more than 25 countries within medical, cancer research ...

CHICAGO--(BUSINESS WIRE)-- MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company developing ...

SANTA ANA, Calif., Oct. 08, 2024 (GLOBE NEWSWIRE) -- NKGen Biotech Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and ...